1
Edward E Beedle, David W Robertson, David T Wong: Serotonin antagonists. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, May 7, 1991: US05013761 (60 worldwide citation)

This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Novel aryloxypropanolamines are also claimed.


2
Edward E Beedle, David W Robertson, David T Wong: Cycloalkylaminoalkoxyindoles. Eli Lilly and Company, Joseph A Jones, May 30, 1995: US05420294 (12 worldwide citation)

This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.


3
Edward E Beedle, David W Robertson: Anticonvulsant agents. Eli Lilly and Company, Robert A Conrad, Arthur R Whale, December 30, 1986: US04632939 (10 worldwide citation)

This invention provides certain benzamide derivatives of the formula: ##STR1## wherein Z is bond, --CH.sub.2 --, or CHCH.sub.3 ; A is --CH.sub.2 --, or CH.sub.2 CH.sub.2 --; and represents a single or double bond; and their pharmaceutical formulations and their use as anticonvulsant agents.


4
Edward E Beedle, David W Robertson: Intermediates for anticonvulsant agents. Eli Lilly and Company, Charles W Ashbrook, Robert A Conrad, February 10, 1987: US04642379 (4 worldwide citation)

This invention provides certain 4-acylamino benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.


5
Edward E Beedle, David W Robertson: Anticonvulsant agents. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, January 1, 1991: US04981866 (3 worldwide citation)

This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.


6
Edward E Beedle, David W Robertson, David T Wong: Use of propanolamine derivatives as selective 5-HT.sub.1 antagonists. Eli Lilly and Company, Joseph A Jones, September 10, 1996: US05554640

This invention provides a method of selectively antagonizing-the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.


7
Edward E Beedle, David W Robertson: Anticonvulsant agents. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, July 3, 1990: US04939163

This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.


8
Edward E Beedle, David W Robertson: Anticonvulsant agents using cyano dimethylphenyl benzamides. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, May 30, 1989: US04835181

This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.



Click the thumbnails below to visualize the patent trend.